LXRX - Lexicon Pharmaceuticals, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.33 0.01 (0.75%) 0.0 (0.0%) 0.01 (0.37%) 0.01 (0.37%) 0.03 (2.26%) 0.02 (1.52%) 0.0 (0.0%) 0.02 (1.49%)

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.01
Diluted EPS:
0.01
Basic P/E:
134.0
Diluted P/E:
134.0
RSI(14) 1m:
62.89
VWAP:
1.34
RVol:

Events

Period Kind Movement Occurred At

Related News